FIELD: pharmaceutics.
SUBSTANCE: invention refers to medicinal preparations, namely to agents for treatment and / or prevention of liver diseases. Pharmaceutical composition contains phospholipids, glycyrrhizinic acid or its sodium salt, vitamin E and water. In the most optimal version of composition phospholipids composition contains phosphatidylcholine, and as vitamin E contains alpha-tocopherol or alpha-tocopherol acetate.
EFFECT: such composition provides duration of storage of a liquid form of a mixture of phospholipids and glycyrrhizinic acid of not less than the storage life of the lyophilizate without using preserving agents and stabilizers with negative side properties.
3 cl, 5 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION FOR INJECTION BASED ON PHOSPHOTIDYLCHOLINE, METHIONINE, VITAMIN E AND SODIUM SELENITE - "HEPARS", WHICH HAS HEPATOPROTECTIVE PROPERTIES, AND A METHOD FOR ITS PREPARATION | 2020 |
|
RU2760685C1 |
| COMPOSITION EXHIBITING PROPERTY FOR BIOLOGICAL MEMBRANE REPAIRING | 1998 |
|
RU2133122C1 |
| METHOD FOR PREPARING INJECTION MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304430C2 |
| NANOFORM OF PHOSPHOLIPID PREPARATION FOR ORAL APPLICATION AND METHOD FOR MAKING THEREOF | 2008 |
|
RU2373924C1 |
| METHOD FOR PREPARING CAPSULATED MEDICINAL FORMULATION OF PHOSPHOLIPID PREPARATION "FOSFOGLIV" FOR TREATMENT AND PROPHYLAXIS OF ACUTE AND CHRONIC HEPATIC DISEASES | 2005 |
|
RU2304431C2 |
| METHOD FOR PREPARING MAGNET-SENSITIVE LIPID COMPOSITE | 2012 |
|
RU2502505C2 |
| METHOD OF PRODUCING LIPOSOMAL COSMETIC SERUM IN DRY LYOPHILIZED FORM FOR FACE, NECK AND CLEAVAGE SKIN CARE | 2023 |
|
RU2825130C1 |
| LIPOSOMAL ANTIVIRAL DRUG FOR ORAL USING | 1996 |
|
RU2123328C1 |
| USING PHOSPHOLIPID-CONTAINING COMPOSITION FOR REMOVING SUBCUTANEOUS FAT BY SUBCUTANEOUS LYPOLYSIS | 2011 |
|
RU2549966C2 |
| PHARMACEUTICAL COMPOSITION BASED ON DOXORUBICINE AND PHOSPHOLIPID NANOPARTICLES FOR TREATMENT OF ONCOLOGIC DISEASES | 2009 |
|
RU2411935C1 |
